Several of the key regulators of transcription involved in mesenchymal transformation (e.g., NF-κB, CEBP-β) upregulate under hypoxic conditions in cancer cells [27,32], and hypoxia activates the JAK2/STAT5b pathway in several types of cancer [20,21,22,23]. Here, NFKB1 is linked to cancer.